Study site (year of study)a
|
No. of children
|
Gender
|
Age (year)
|
Weight (kg)
|
Duration (days)
|
Temperature (°C)
|
Haematocrit (%)
|
Degree of anaemia
|
Parasitaemia (μL−1)
|
---|
M/F
|
Mean ± sd (Range)
|
No. <1 year
|
Mean ± sd (Range)
|
Mean ± sd (Range)
|
Mean ± sd (Range)
|
No. >37.4 °C
|
No. ≥40 °C
|
Mean ± sd (Range)
|
No. < 30 %
|
Mild
|
Moderate
|
Severe
|
Geometric mean (Range)
|
No. >100,000 μL−1
|
---|
Ibadan (2005–2010)
|
47
|
26/21
|
1.7 ± 0.4 (0.7–2)
|
4
|
9.7 ± 2.5 (6–17)
|
2.9 ± 1.5 (1–7)
|
38.5 ± 1.1 (36.1–40.8)
|
39
|
2
|
28.3 ± 4.5 (20–38)
|
26
|
23
|
3
|
-
|
30,924 (1,614–304,500)
|
7
|
Damboa (2009–2010)
|
24
|
16/8
|
1.5 ± 0.5 (0.5–2)
|
7
|
9.9 ± 3.9 (5–20)
|
-
|
37.9 ± 0.6 (37.5–39.3)
|
24
|
-
|
27.9 ± 5.9 (14–36)
|
12
|
9
|
2
|
1
|
5,988 (1,000–123,774)
|
1
|
Agbani (2009–2010)
|
57
|
24/33
|
1.3 ± 0.5 (0.5–2)
|
20
|
9.9 ± 1.7 (5–17)
|
-
|
37.6 ± 1.1 (35.6–40.3)
|
30
|
1
|
27.3 ± 4.3 (18–40)
|
38
|
33
|
5
|
-
|
10,343 (1,018–155,520)
|
3
|
Makarfi (2009–2010)
|
41
|
24/17
|
1.4 ± 0.4 (0.5–2)
|
15
|
8.4 ± 1.6 (5–12)
|
-
|
37.9 ± 1 (36–39.4)
|
29
|
-
|
29.4 ± 5.1 (16–37)
|
15
|
13
|
2
|
-
|
10,208 (1,301–112,421)
|
2
|
Ijede (2009–2010)
|
28
|
18/10
|
1.4 ± 0.4 (0.6–2)
|
6
|
9.2 ± 1.6 (5–12)
|
-
|
38.1 ± 1.4 (36–40.3)
|
18
|
4
|
28.9 ± 4.8 (19–38)
|
16
|
14
|
2
|
-
|
10,788 (1,071–78,769)
|
-
|
Barkin Ladi (2009–2010)
|
39
|
20/19
|
1.6 ± 0.5 (0.6–2)
|
8
|
10.6 ± 2.3 (7–15)
|
3.1 ± 1 (1–7)
|
37.9 ± 1 (36.1–40)
|
30
|
1
|
30.7 ± 4.2 (22–40)
|
13
|
13
|
-
|
-
|
17,336 (2,132–104,154)
|
1
|
Ibadan (2011–2015)
|
14
|
11/3
|
1.4 ± 0.6 (0.5–2)
|
5
|
9.2 ± 2.8 (5–14)
|
3 ± 0.7 (2–4)
|
38.1 ± 1.3 (36.3–40)
|
9
|
1
|
29 ± 4.1 (22–37)
|
7
|
7
|
-
|
-
|
23,326 (2,924–114,504)
|
-
|
ALL (2005–2015)
|
250
|
139/111
|
1.5 ± 0.5 (0.5–2)
|
65
|
9.6 ± 2.3 (5–20)
|
3 ± 1.2 (1–7)
|
38 ± 1.1 (35.6–40.8)
|
179
|
9
|
28.7 ± 4.8 (14–40)
|
127
|
112
|
14
|
1
|
13,714 (1000–304,500)
|
16
|
P value
|
-
|
0.14
|
0.03
|
0.03
|
0.001
|
0.83
|
0.01
|
0.02
|
0.29
|
0.03
|
0.02
|
0.85
|
0.99
|
-
|
<0.0001
|
0.11
|
-
sd standard deviation
-
aartesunate-amodiaquine and artemether-lumefantrine were evaluated at all sites